Survival in Patients With Stage III Lung Cancer Hampered by Higher Dose of Radiotherapy

Compared with standard-dose (SD), high-dose radiotherapy (RT) with concurrent chemotherapy (CT) did not improve overall survival of patients with stage III non-small-cell lung cancer (NSCLC), results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) have indicated. Philadelphia, PA-Of all the patients in the US with lung cancer, the country's leading cause of cancer death, 75 to 80 percent of them have NSCLC, with ...

via Medindia Health News More READ

For a Free Step By Step Guide for Dating Dos and Don'ts check http://end2endwebs.com

Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/06/survival-in-patients-with-stage-iii.html